Filing Flows › HeartSciences (HSCS) › R&D spending
HeartSciences (HSCS) R&D spending by quarter
HeartSciences' R&D spending was $907K in Q1 FY27 (first quarter fiscal 2027), +25% from Q2 FY26. Over the last 4 quarters it ranged from $727K (Q2 FY26) to $997K (Q1 FY26).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $907K | +25% | -9% |
| Q2 FY26 | $727K | -27% | — |
| Q1 FY26 | $997K | +7% | — |
| Q4 FY25 | $929K | — | — |
Q1 FY27 at a glance
HeartSciences, Q1 FY27: revenue $2K (+10% year over year), net loss $3.2M, operating cash flow −$1.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is HeartSciences' R&D spending?
HeartSciences' R&D spending was $907K in Q1 FY27 (first quarter fiscal 2027), +25% from Q2 FY26.
How has HeartSciences' R&D spending changed?
Over the last 4 quarters it ranged from $727K (Q2 FY26) to $997K (Q1 FY26).